(Q33709280)

28 July 2017

1 reference

title

Immunopharmacology: anti-inflammatory therapy targeting transcription factors (English)

1 reference

28 July 2017

1 reference

Pfeilschifter J

1

1 reference

28 July 2017

Mühl H

series ordinal

2

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

European Journal of Pharmacology

28 July 2017

published in

1 reference

28 July 2017

volume

375

1 reference

28 July 2017

issue

1-3

1 reference

28 July 2017

page(s)

237-245

1 reference

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Interleukin-1 receptor antagonist: role in biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Anti-inflammatory actions of steroids: molecular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Macrophage deactivation by interleukin 10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Transcriptional analyses of steroid-regulated gene networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

The physiologic basis for anticytokine clinical trials in the treatment of sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Molecular mechanisms of anti-inflammatory action of glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Regulation of autoimmunity by proinflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Overview of interleukin-18: more than an interferon-gamma inducing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Taming TNF: strategies to restrain this proinflammatory cytokine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Gene therapy for rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Anticytokine therapy in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Clinical, hematologic, and immunologic effects of interleukin-10 in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Regulation of gene expression by small molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Determinants of promoter-specific activity by glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Pro- and anti-inflammatory cytokines in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Inhibition of NF-kappa B by sodium salicylate and aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Interleukin-10: biology, role in inflammation and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

FK506 and cyclosporin, molecular probes for studying intracellular signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Signal transduction through NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Transforming growth factors type-beta and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin-1 and forskolin in rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Cyclosporin derivatives inhibit interleukin 1 beta induction of nitric oxide synthase in renal mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Cloning of a new cytokine that induces IFN-gamma production by T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Identification of mRNAs associated with programmed cell death in immature thymocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Transcription-factor-modulating agents: precision and selectivity in drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Transcription factor based therapeutics: drugs of the future?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Transforming growth factor β2 inhibits interleukin 1β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Transforming growth factor beta 2 differentially modulates interleukin-1 beta- and tumour-necrosis-factor-alpha-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Glucocorticoid signalling--multiple variations of a common theme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Interleukin-1 beta-induced cytosolic phospholipase A2 activity and protein synthesis is blocked by dexamethasone in rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

The mechanism of action of cyclosporin A and FK506

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Liposomes as agents of DNA transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Proinflammatory cytokines and treatment of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-tr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Suppression by cyclosporin A of interleukin 1 beta-induced expression of group II phospholipase A2 in rat renal mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Glucocorticoids and immune function: unknown dimensions and new frontiers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Involvement and dual effects of nitric oxide in septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Structural determinants of DNA-binding specificity by steroid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

Blocking cytokines with genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Relevance of platelet-activating factor in inflammation and sepsis: mechanisms and kinetics of removal in extracorporeal treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900361-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00361-1

1 reference

28 July 2017

1 reference